Litcius/Paper detail

The CIRCULATE Trial: Circulating Tumor DNA Based Decision for Adjuvant Treatment in Colon Cancer Stage II Evaluation (AIO-KRK-0217)

Gunnar Folprecht, Anke Reinacher‐Schick, Jürgen Weitz, Céline Lugnier, Anna‐Lena Kraeft, Sarah Wisser, Daniela E. Aust, Lukas Weiß, Nikolas von Bubnoff, Michael Krämer, Christian Thiede, Andrea Tannapfel

2021Clinical Colorectal Cancer39 citationsDOI

Topics & Concepts

MedicineColorectal cancerInternal medicineOncologyOxaliplatinCapecitabineMicrosatellite instabilityHazard ratioStage (stratigraphy)Randomized controlled trialClinical trialAdjuvantCancerConfidence intervalMicrosatelliteAlleleChemistryBiologyPaleontologyBiochemistryGeneCancer Genomics and DiagnosticsColorectal Cancer Treatments and StudiesGenetic factors in colorectal cancer
The CIRCULATE Trial: Circulating Tumor DNA Based Decision for Adjuvant Treatment in Colon Cancer Stage II Evaluation (AIO-KRK-0217) | Litcius